Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

12.23
-0.7800-6.00%
Post-market: 12.230.00000.00%17:47 EDT
Volume:221.31K
Turnover:2.69M
Market Cap:398.21M
PE:-13.12
High:12.68
Open:12.40
Low:11.83
Close:13.01
Loading ...

Neuropace Inc : UBS Initiates Coverage With Buy Rating; Target Price $17

THOMSON REUTERS
·
21 Jan

NeuroPace initiated with a Buy at UBS

TIPRANKS
·
21 Jan

NeuroPace to Present at J.P. Morgan Healthcare Conference

TIPRANKS
·
16 Jan

Promising Outlook for NeuroPace: Revenue Beats, Clinical Progress, and Growth Catalysts

TIPRANKS
·
13 Jan

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Tecan Group AG (OtherTCHBF) and Avidity Biosciences (RNA)

TIPRANKS
·
09 Jan

NeuroPace Sees Rise in 4Q, Full-Year Sales

Dow Jones
·
09 Jan

NeuroPace Strengthens Board and Reports Strong 2024 Results

TIPRANKS
·
09 Jan

NeuroPace Preliminary Q4 Revenue Increases; Shares Rise After Hours

MT Newswires Live
·
09 Jan

Neuropace Inc - Preliminary Q4 2024 Revenue Expected Between $21.0 Mln and $21.5 Mln

THOMSON REUTERS
·
09 Jan

NeuroPace reports sees Q4 revenue $21M-$21.5M, consensus $20.91M

TIPRANKS
·
09 Jan

NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M

TIPRANKS
·
09 Jan

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

GlobeNewswire
·
09 Jan

Institutions profited after NeuroPace, Inc.'s (NASDAQ:NPCE) market cap rose US$37m last week but private equity firms profited the most

Simply Wall St.
·
08 Jan

NeuroPace (NPCE) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
26 Dec 2024

Positive Outlook for NeuroPace: Anticipated Success of NAUTILUS Study and Strategic Market Advantage

TIPRANKS
·
21 Dec 2024

NeuroPace Is Maintained at Overweight by JP Morgan

Dow Jones
·
18 Dec 2024

NeuroPace: Undervalued Innovator in the Drug-Resistant Epilepsy Market with Promising Long-Term Growth

TIPRANKS
·
17 Dec 2024

NeuroPace price target raised to $14 from $9 at JPMorgan

TIPRANKS
·
17 Dec 2024

U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart

Reuters
·
17 Dec 2024

NeuroPace to Host Investor Day on January 28th in New York City

GlobeNewswire
·
13 Dec 2024